Skip to search formSkip to main contentSkip to account menu

Nimustine Hydrochloride

Known as: 3-((4-Amino-2-Methyl-5-Pyrimidinyl)Methyl)-1-(2-Chloroethyl)-1-Nitrosourea Hydrochloride, ACNU HCl, N'-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitrosourea Hydrochloride 
The hydrochloride salt of nimustine, a nitrosourea with antineoplastic activity. Nimustine alkylates and crosslinks DNA, thereby causing DNA… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
PURPOSE A major adverse effect arising from nimustine hydrochloride (ACNU) therapy for brain tumors is myelosuppression. Because… 
2007
2007
We retrospectively evaluated early and long-term complications of an intensified conditioning regimen consisting of busulfan and… 
2007
2007
Loss of the PTEN tumor suppressor gene and amplification of the epidermal growth factor receptor (EGFR), which is common in… 
2000
2000
Twenty-eight patients who were previously treated by aggressive surgery and radiation and were diagnosed with supratentorial… 
1999
1999
Melanoma is an uncommon disease in Japan. The incidence, however, has been gradually increasing in the last two decades, as in… 
1990
1990
As an adjunct to cancer chemotherapy, we had succeeded in creating the methionine depletion in vivo, using the technique of total… 
1989
1989
Nimustine hydrochloride (ACNU) is a nitrosourea derivative anticancer agent which has been shown to cause persistent truncus…